Reports

Ideas That Generate Results

List of Figures:

Figure 3-1: Schematic Diagram of Sequencing used for Human Genome Project
Figure 3-2: Long-range Sequence Assembly in Whole Genome Shotgun Sequencing
Figure 4-1: Cancer Prevalence (Million), 2010-2018
Figure 4-2: Cancer Incidences (Million), 2010-2018
Figure 4-3: Cancer Mortality (‘000), 2010-2018
Figure 4-4: Incidences by Type of Cancer (%), 2014
Figure 4-5: Cancer Incidences by Age Group (%), 2010
Figure 5-1: Number of People earning > US$ 100K (2009-2012)
Figure 5-2: Potential Customers for Personalized Cancer WGS Market (Billion), 2013-2018
Figure 5-3: Potential Customers for Personalized Cancer WGS Market by Age-Group (%), 2014
Figure 5-4: Potential Market for Personalized Cancer WGS (Billion US$), 2013-2018
Figure 6-1: Tapped and Untapped Personalized Cancer WGS Market (%), 2014
Figure 6-2: Personalized Cancer WGS Market (Million US$), 2013-2018

List of Tables:

Table 4-1: Top Ten States with Highest Cancer Incidences (‘000), 2014
Table 4-2: Top Ten Cancer Incidences in Males (2014)
Table 4-3: Top Ten Cancer Incidences in Females (2014)
Table 5-1: Top Ten States with Households earning > US$ 100K (2012)
Table 5-2: Key Demographics and Potential Customers for Personalized Cancer WGS Market (2014)
Table 5-3: Potential States for Personalized Cancer Whole Genome Sequencing
Table 9-1: Illumina - Key information
Table 9-2: Complete Genomics - Key Information
Table 9-3: Beckman Coulter Genomics - Key Information
Table 9-4: Expression Analysis - Key Information
Table 9-5: Edge Bio - Key Information
Table 9-6: Foundation Medicine - Key Information
Table 9-7: SeqWright - Key Information
Table 9-8: Ambry Genetics - Key Information
Table 9-9: BGI Americas Corporation - Key Information
Table 9-10: Cofactor Genomics - Key Information